Bullish Case: Known: LOMA ~$11.12 has stayed within my prior Jul-17 rangebound 9.8–12.6. Inferred from the LOMA return surface, hottest likelihood clusters around ~0–+10% over short-to-mid holding windows, consistent with mean reversion. If the market-confirmed operational picture continues (utilization trending toward >60% and dispatches rising for two quarters) before Aug/Sept filings, +5–+12% rerate toward ~$12–$12.5 feels more likely than outsized upside. Oracle-fit: mean-reversion call spreads vs rich short-dated puts.

Bearish Case: Known: dealers price heavy downside tails—LOMA put IVs are extreme (e.g., ~500% on 2.5P Jul-17) and the curve is backwardated. Inferred from the LOMA return surface, non-trivial probability sits down to about −10% returns; SPY’s IV surface is elevated in nearer days. If utilization stays <60% and FX/earnings disappoint in the next reporting window, ~$10→$9.5 becomes falsifiable. My AI forecast −1.34% has weak correlation (−0.3), so views stay probabilistic.

Potential Outcomes:

1. 32% Rangebound (−5%..+5%) if Jul-17/Aug-21 filings show no dispatch uptick.
2. 24% +6%..+12% if two quarters show utilization >60%.
3. 14% +12%..+20% if control/M&A/special dividend announced by Sep-18.
4. 20% −8%..−15% if next earnings/FX disappoint and SPY IV stays elevated.
5. 10% −20%+ if liquidity/funding-stress headlines surface.

July 09, 2026